Cureskin has raised $20 million in Series B funding to enhance its AI-driven skincare platform, addressing the growing demand for accessible dermatological care in India.

Target Information

Cureskin is an innovative platform that connects users with skincare experts and has successfully raised $20 million in a Series B funding round, led by HealthQuad, a prominent healthcare-focused venture capital firm. This latest funding round saw participation from existing investors such as JSW Ventures, Khosla Ventures, and Sharrp Ventures, bringing Cureskin's total funding to $26 million.

The company, founded in 2017 by Guna Kakulapati, Ramakrishna Rajanna, and Charu Sharma, has developed a unique mobile application that employs photo-analysis technology. This technology analyzes over 10 million skin pixels to derive more than 2,000 facial attributes, enabling users to understand their skin conditions and assess their severity. Cureskin leverages a vast database consisting of over 50 million images to provide accurate assessments.

Industry Overview

The Indian beauty and personal care market is experiencing significant growth, with a projected compound annual growth rate (CAGR) of 10% from 2022 to 2027. This growth trajectory indicat